Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chezmar, J. L.
Right arrow Articles by Bernardino, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chezmar, J. L.
Right arrow Articles by Bernardino, M. E.

Radiology, Vol 168, 43-47, Copyright © 1988 by Radiological Society of North America


ARTICLES

Liver and abdominal screening in patients with cancer: CT versus MR imaging

JL Chezmar, WM Rumancik, AJ Megibow, DH Hulnick, RC Nelson and ME Bernardino
Department of Radiology, Emory University School of Medicine, Atlanta, GA 30322.

A prospective multiinstitutional study was performed to compare the ability of dynamic sequential contrast material-enhanced computed tomography (CT), delayed contrast material-enhanced CT, and two T1- weighted magnetic resonance (MR) sequences (spin echo and inversion recovery) to demonstrate metastatic disease in the liver and abdomen in patients with cancer. All four techniques had comparable rates of hepatic lesion detection when compared individually or when the combined CT techniques were compared with the combined MR techniques. The sensitivity to hepatic disease was 96% (27 of 28 patients) for the combined MR techniques versus 93% (26 of 28 patients) for the combined CT techniques. However, CT was statistically superior in the detection of extrahepatic disease, with significant extrahepatic findings demonstrated by CT in only 12 of 59 patients (20%). For this reason, the authors continue to recommend CT in the initial screening of patients with cancer for upper abdominal metastatic disease.


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
V Trillet-Lenoir, G Freyer, P Kaemmerlen, A Fond, O Pellet, C Lombard-Bohas, J L Gaudin, G Lledo, R Mackiewicz, M C Gouttebel, et al.
Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria
Br. J. Radiol., November 1, 2002; 75(899): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. N. Low, R. C. Semelka, S. Worawattanakul, G. D. Alzate, and J. S. Sigeti
Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation
Radiology, March 1, 1999; 210(3): 625 - 632.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1988 by the Radiological Society of North America.